SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1gh2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2S_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.47A 1k2sA-1gh2A:
0.0
1k2sB-1gh2A:
0.0
1k2sA-1gh2A:
12.29
1k2sB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2T_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.47A 1k2tA-1gh2A:
0.4
1k2tB-1gh2A:
0.0
1k2tA-1gh2A:
12.29
1k2tB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2T_B_H4BB2760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.46A 1k2tA-1gh2A:
0.4
1k2tB-1gh2A:
0.0
1k2tA-1gh2A:
12.29
1k2tB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1K2U_A_H4BA1760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.43A 1k2uA-1gh2A:
0.0
1k2uB-1gh2A:
0.0
1k2uA-1gh2A:
12.29
1k2uB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZZ_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.44A 1lzzA-1gh2A:
0.0
1lzzB-1gh2A:
0.0
1lzzA-1gh2A:
12.29
1lzzB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LZZ_B_H4BB1760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.49A 1lzzA-1gh2A:
0.0
1lzzB-1gh2A:
0.0
1lzzA-1gh2A:
12.29
1lzzB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M00_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.43A 1m00A-1gh2A:
0.0
1m00B-1gh2A:
0.0
1m00A-1gh2A:
12.29
1m00B-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OM5_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 8 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.48A 1om5A-1gh2A:
undetectable
1om5B-1gh2A:
0.0
1om5A-1gh2A:
12.22
1om5B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6I_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.44A 1p6iA-1gh2A:
0.0
1p6iB-1gh2A:
0.0
1p6iA-1gh2A:
12.22
1p6iB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P6J_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.50A 1p6jA-1gh2A:
0.0
1p6jB-1gh2A:
0.0
1p6jA-1gh2A:
12.22
1p6jB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS7_A_H4BA760_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.43A 1rs7A-1gh2A:
0.0
1rs7B-1gh2A:
0.0
1rs7A-1gh2A:
12.22
1rs7B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RS7_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.44A 1rs7A-1gh2A:
0.0
1rs7B-1gh2A:
0.0
1rs7A-1gh2A:
12.22
1rs7B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZVL_A_H4BA900_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.49A 1zvlA-1gh2A:
0.0
1zvlB-1gh2A:
0.0
1zvlA-1gh2A:
11.90
1zvlB-1gh2A:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G6K_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.38A 2g6kA-1gh2A:
0.0
2g6kB-1gh2A:
0.0
2g6kA-1gh2A:
12.29
2g6kB-1gh2A:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B3P_B_H4BB760_1
(NITRIC-OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 8 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.48A 3b3pA-1gh2A:
0.0
3b3pB-1gh2A:
0.1
3b3pA-1gh2A:
12.22
3b3pB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FC5_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.46A 3fc5A-1gh2A:
0.0
3fc5B-1gh2A:
0.0
3fc5A-1gh2A:
12.22
3fc5B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FC5_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.46A 3fc5A-1gh2A:
0.0
3fc5B-1gh2A:
0.0
3fc5A-1gh2A:
12.22
3fc5B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.50A 3jt3A-1gh2A:
0.0
3jt3B-1gh2A:
0.2
3jt3A-1gh2A:
12.22
3jt3B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT4_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.40A 3jt4A-1gh2A:
0.5
3jt4B-1gh2A:
0.0
3jt4A-1gh2A:
12.22
3jt4B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT7_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.45A 3jt7A-1gh2A:
0.0
3jt7B-1gh2A:
0.0
3jt7A-1gh2A:
12.22
3jt7B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JT9_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.47A 3jt9A-1gh2A:
0.0
3jt9B-1gh2A:
0.0
3jt9A-1gh2A:
12.22
3jt9B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JTA_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.42A 3jtaA-1gh2A:
0.0
3jtaB-1gh2A:
0.0
3jtaA-1gh2A:
12.22
3jtaB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JTA_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.46A 3jtaA-1gh2A:
0.0
3jtaB-1gh2A:
0.0
3jtaA-1gh2A:
12.22
3jtaB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX0_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.41A 3jx0A-1gh2A:
0.2
3jx0B-1gh2A:
0.0
3jx0A-1gh2A:
11.94
3jx0B-1gh2A:
11.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5V_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.46A 3n5vA-1gh2A:
0.0
3n5vB-1gh2A:
0.1
3n5vA-1gh2A:
12.22
3n5vB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N5Y_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.49A 3n5yA-1gh2A:
0.0
3n5yB-1gh2A:
0.0
3n5yA-1gh2A:
12.22
3n5yB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLK_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.37A 3nlkA-1gh2A:
0.0
3nlkB-1gh2A:
0.0
3nlkA-1gh2A:
12.22
3nlkB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLW_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.50A 3nlwA-1gh2A:
0.0
3nlwB-1gh2A:
0.0
3nlwA-1gh2A:
12.22
3nlwB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NNZ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.38A 3nnzA-1gh2A:
0.0
3nnzB-1gh2A:
0.0
3nnzA-1gh2A:
12.22
3nnzB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PNG_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.43A 3pngA-1gh2A:
0.0
3pngB-1gh2A:
0.0
3pngA-1gh2A:
12.22
3pngB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q99_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.44A 3q99A-1gh2A:
0.0
3q99B-1gh2A:
0.2
3q99A-1gh2A:
12.22
3q99B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.47A 3rqlA-1gh2A:
0.0
3rqlB-1gh2A:
0.0
3rqlA-1gh2A:
12.22
3rqlB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RQM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.42A 3rqmA-1gh2A:
0.0
3rqmB-1gh2A:
0.0
3rqmA-1gh2A:
12.22
3rqmB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYL_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.49A 3tylA-1gh2A:
0.0
3tylB-1gh2A:
0.0
3tylA-1gh2A:
12.22
3tylB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYL_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.48A 3tylA-1gh2A:
0.0
3tylB-1gh2A:
0.0
3tylA-1gh2A:
12.22
3tylB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYM_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.48A 3tymA-1gh2A:
0.0
3tymB-1gh2A:
0.0
3tymA-1gh2A:
12.22
3tymB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYM_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.42A 3tymA-1gh2A:
0.0
3tymB-1gh2A:
0.0
3tymA-1gh2A:
12.22
3tymB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYN_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.47A 3tynA-1gh2A:
0.0
3tynB-1gh2A:
0.0
3tynA-1gh2A:
12.22
3tynB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYN_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.48A 3tynA-1gh2A:
0.0
3tynB-1gh2A:
0.0
3tynA-1gh2A:
12.22
3tynB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.49A 3tyoA-1gh2A:
0.0
3tyoB-1gh2A:
0.0
3tyoA-1gh2A:
12.22
3tyoB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TYO_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.48A 3tyoA-1gh2A:
0.0
3tyoB-1gh2A:
0.0
3tyoA-1gh2A:
12.22
3tyoB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CAQ_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.50A 4caqA-1gh2A:
0.0
4caqB-1gh2A:
0.0
4caqA-1gh2A:
12.22
4caqB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CDT_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.46A 4cdtA-1gh2A:
0.0
4cdtB-1gh2A:
0.0
4cdtA-1gh2A:
12.22
4cdtB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.48A 4ctrA-1gh2A:
0.2
4ctrB-1gh2A:
0.0
4ctrA-1gh2A:
12.22
4ctrB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTU_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.45A 4ctuA-1gh2A:
0.0
4ctuB-1gh2A:
0.0
4ctuA-1gh2A:
12.22
4ctuB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CTX_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.45A 4ctxA-1gh2A:
0.0
4ctxB-1gh2A:
0.0
4ctxA-1gh2A:
12.22
4ctxB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D1N_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.41A 4d1nA-1gh2A:
0.0
4d1nB-1gh2A:
0.0
4d1nA-1gh2A:
11.90
4d1nB-1gh2A:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Y_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.38A 4d2yA-1gh2A:
0.0
4d2yB-1gh2A:
0.0
4d2yA-1gh2A:
12.22
4d2yB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Y_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.39A 4d2yA-1gh2A:
0.0
4d2yB-1gh2A:
0.0
4d2yA-1gh2A:
12.22
4d2yB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D2Z_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.37A 4d2zA-1gh2A:
0.4
4d2zB-1gh2A:
0.0
4d2zA-1gh2A:
12.22
4d2zB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D30_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.49A 4d30A-1gh2A:
0.0
4d30B-1gh2A:
0.2
4d30A-1gh2A:
12.22
4d30B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D32_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 8 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.37A 4d32A-1gh2A:
0.0
4d32B-1gh2A:
0.0
4d32A-1gh2A:
12.22
4d32B-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D7O_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.39A 4d7oA-1gh2A:
0.0
4d7oB-1gh2A:
0.0
4d7oA-1gh2A:
12.22
4d7oB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4D7O_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.39A 4d7oA-1gh2A:
0.0
4d7oB-1gh2A:
0.0
4d7oA-1gh2A:
12.22
4d7oB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVX_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.42A 4fvxA-1gh2A:
0.0
4fvxB-1gh2A:
0.0
4fvxA-1gh2A:
12.22
4fvxB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FVZ_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.49A 4fvzA-1gh2A:
0.0
4fvzB-1gh2A:
0.0
4fvzA-1gh2A:
12.22
4fvzB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4GQE_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.50A 4gqeA-1gh2A:
0.0
4gqeB-1gh2A:
0.0
4gqeA-1gh2A:
12.22
4gqeB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4IMT_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.41A 4imtA-1gh2A:
0.0
4imtB-1gh2A:
0.0
4imtA-1gh2A:
12.22
4imtB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSE_A_H4BA804_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.36A 4jseA-1gh2A:
0.0
4jseB-1gh2A:
0.0
4jseA-1gh2A:
12.22
4jseB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JSE_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.39A 4jseA-1gh2A:
0.0
4jseB-1gh2A:
0.0
4jseA-1gh2A:
12.22
4jseB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5F_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.50A 4k5fA-1gh2A:
0.1
4k5fB-1gh2A:
0.1
4k5fA-1gh2A:
12.22
4k5fB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K5G_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.49A 4k5gA-1gh2A:
0.0
4k5gB-1gh2A:
0.0
4k5gA-1gh2A:
12.22
4k5gB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCH_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.42A 4kchA-1gh2A:
0.0
4kchB-1gh2A:
0.0
4kchA-1gh2A:
12.22
4kchB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCH_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.41A 4kchA-1gh2A:
0.0
4kchB-1gh2A:
0.0
4kchA-1gh2A:
12.22
4kchB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KCI_B_H4BB802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.49A 4kciA-1gh2A:
0.0
4kciB-1gh2A:
0.0
4kciA-1gh2A:
12.22
4kciB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3X_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.40A 4v3xA-1gh2A:
0.0
4v3xB-1gh2A:
0.0
4v3xA-1gh2A:
12.22
4v3xB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3X_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.43A 4v3xA-1gh2A:
0.0
4v3xB-1gh2A:
0.0
4v3xA-1gh2A:
12.22
4v3xB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V3Z_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 PHE A  79
GLU A 100
MET A  47
VAL A  26
None
1.44A 4v3zA-1gh2A:
0.0
4v3zB-1gh2A:
0.0
4v3zA-1gh2A:
12.22
4v3zB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VUN_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.39A 5vunA-1gh2A:
0.0
5vunB-1gh2A:
0.0
5vunA-1gh2A:
12.22
5vunB-1gh2A:
12.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AUS_A_H4BA802_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1gh2 THIOREDOXIN-LIKE
PROTEIN

(Homo
sapiens)
4 / 7 MET A  47
VAL A  26
PHE A  79
GLU A 100
None
1.42A 6ausA-1gh2A:
0.0
6ausB-1gh2A:
0.0
6ausA-1gh2A:
19.82
6ausB-1gh2A:
19.82